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The binding and uptake of 59Fe-loaded ‘H-labelled rat transferrin by cultured rat hepatocytes was 
investigated. At 4”C, there is no evidence for a specific binding of transferrin which could be related to 
the association of neo-synthesized transferrin with plasma membrane receptors. At 37”C, iron uptake is 
much more important than transferrin uptake; it proceeds linearly over the time of incubation, is largely 
proportional to the extracellular transferrin concentration, and is compatible with uptake by fluid phase 
endocytosis. The difference observed between iron and transferrin uptake implies the existence of a 
mechanism allowing the reutilization of transferrin after iron delivery. 
Transferrin Iron Uptake 
1. INTRODUCTION 
Hepatocytes play a key role in iron metabolism. 
They synthesize transferrin, the transport protein 
for iron in serum and extracellular fluids, as well as 
haptoglobin and haemopexin which recover haem 
after intravascular haemolysis [ 11. They clear from 
the circulation the haptoglobin-haemoglobin com- 
plex by receptor-mediated endocytosis. This per- 
mits the release of iron for incorporation into 
hepatic ferritin [2], and the transfer of haptoglobin 
to the bile [3-51 or its delivery to lysosomes for 
digestion [4]. The haem-haemopexin complex is 
taken up by hepatocytes through receptor- 
mediated endocytosis with either recycling of 
haemopexin [6] or its digestion in lysosomes with 
recycling of iron to transferrin [7], incorporation 
of iron into ferritin, and secretion of oxidised 
haem in the bile. Hepatocytes also accumulate iron 
from transferrin [2,8,9] or from ferric citrate [9]. 
Several mechanisms have been proposed for 
transferrin iron uptake by different cell types. 
Once bound to a cell surface receptor [lo], 
transferrin could release its iron at the plasma 
membrane and thereafter return to the ex- 
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tracellular medium while the iron could pass into 
the cytoplasm. Alternatively, in agreement with 
morphological observations [ 11,121, transferrin 
could be interiorised by endocytosis and release its 
iron within an intracellular acidic granule prior to 
its recycling and release in the extracellular 
medium. Such a mechanism seems to be involved 
in transferrin iron uptake by fibroblasts [13-E], 
teratocarcinoma cells [ 161, erythroblasts [ 171 and 
placental trophoblasts [ 181. The mechanism of iron 
uptake by hepatocytes is not understood. On the 
basis of studies on the uptake of iron by rat 
hepatocytes in suspension, it has been proposed 
that after binding of transferrin to specific plasma 
membrane receptors, iron would be incorporated, 
the precise site of iron release being at present 
unknown [19]. It has been suggested that [9] the 
uptake of iron by isolated hepatocytes is related to 
the iron saturation of transferrin. At saturation 
levels of 30% and above, a non-specific uptake 
which is temperature-independent was observed. 
We have investigated the uptake of iron from 
“Fe-saturated 3H-labelled transferrin by cultured 
rat hepatocytes and here report results which show 
a largely non-specific binding of transferrin and 
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uptake of iron by the cells. We propose that this 
could be accounted for by the occupancy of puta- 
tive plasma membrane receptors by neosynthesized 
transferrin secreted into the extracellular medium. 
2. MATERIALS AND METHODS 
Rat serum transferrin was isolated and labelled 
with 3H and 59Fe to a specific radioactivity of 
about 10 000 dpm/pg of protein as in [14]. An- 
tibodies against rat serum transferrin were obtain- 
ed as in [14]. They were purified by immuno- 
adsorption using transferrin immobilised on 
Sepharose CL 4B (Pharmacia, Uppsala) and eluted 
as in [20]. [3H]Inulin (500 mci/mmol) was from 
the Radiochemical Centre (Amersham). 
Rat hepatocytes isolated and cultured as in [21] 
were incubated in 20 cm2 gas permeable Petri 
dishes coated with collagen at 4°C or 37°C in 1 ml 
of culture medium (Dubelco Eagle H16) containing 
15% foetal calf serum (Gibco Biocult, Paisley, 
Scotland). For the 4°C incubations, the medium 
was supplemented with 10 mM HEPES, buffered 
at pH 7.2. At the end of the incubations, cells were 
washed 4-times with 1 ml phosphate-buffered 
saline (PBS), once with culture medium, and twice 
with PBS. The cells were then solubilised with 1% 
(w/v) sodium deoxycholate adjusted to pH 11.3 
with NaOH. The radioactivity accumulated by the 
cells was measured after dispersion in aqualuma 
cocktail (Lumac Systems, Basel) in a Tri Carb 
460 CD scintillation counter (Packard In- 
struments, San Diego CA); all results were cor- 
rected for quenching. 
Cell protein was determined as in [22] using 
bovine serum albumin as standard. The results are 
expressed as dpm/mg cell protein. 
Methylamine was used at a final concentration 
of 20 mM (at this concentration, no toxic effect 
was detected as judged by observation under phase 
contrast microscopy throughout the incubation 
time). For some experiments, the collected media 
was assayed for degradation products after 
precipitation of proteins by 15% (w/v) 
trichloroacetic acid, followed by 30 min at 1500 x 
g and 4°C; the trichloroacetic acid supernatants 
were assayed for radioactivity as above. The secre- 
tion of transferrin in the medium was measured by 
a Particle Counting Immuno Assay (PACIA) 
technique [23] using a monospecific anti- 
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transferrin antiserum and purified transferrin as 
standard. 
3. RESULTS AND DISCUSSION 
3.1. Uptake of 59Fe-saturated 3H-labelled 
transferrin 
That cultured rat hepatocytes accumulate 
transferrin iron and protein is apparent in fig. 1. 
At 37”C, iron uptake proceeds linearly over the en- 
tire period of incubation studied (26 h). In con- 
trast, accumulation of 3H-labelled material in- 
creases linearly up to 7 h and then reaches a 
plateau. At this time, most of the 59Fe is associated 
with cytosol ferritin since about 90% of the in- 
tracellular 59Fe reacts with anti-ferritin IgG im- 
mobilised on Sepharose-protein A as in [ 141. 
Since the initial specific radioactivities in 59Fe 
and 3H are similar, it appears that after 26 h in- 
cubation, the hepatocytes have accumulated about 
16-times more iron than transferrin. Under these 
conditions, no significant amounts of degradation 
products soluble in trichloroacetic acid are 
detected in the culture medium. Thus the dif- 
ference between the accumulation of iron and pro- 
tein cannot be explained by the digestion of 
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Fig. 1. Kinetics of accumulation of iron-saturated 
transferrin by cultured hepatocytes. Cells (-2.5 mg 
protein) were incubated for various times at 37°C in 
20 cm* Petri dishes, in 1 ml of culture medium 
containing 10 pg/ml of (0) “Fe-loaded (m) 3H-labelled 
transferrin (spec. act. 10 000 dpm/pg for both isotopes). 
At the end of the incubation, the cells were washed 
4-times with PBS, dissolved in 1 Vo sodium deoxycholate 
adjusted to pH 11.3 with NaOH, and analysed for 
radioactivity and protein. Mean results + SD of 3 
independent expts are given. 
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transferrin and the release of degradation products 
in the extracellular medium, and there must be a 
mechanism which assures the reutilisation of 
transferrin after iron delivery. 
A few years ago, we proposed a model for 
transferrin iron uptake which permits the reutilisa- 
tion of iron depleted transferrin [13-151. In this 
model, after binding of transferrin to specific 
plasma membrane receptors, the protein is in- 
teriorised by receptor mediated endocytosis; dur- 
ing the fusion of the resulting endocytic vesicle 
with a lysosome or any other prelysosomal acidic 
compartment [24], iron is released from transferrin 
as a consequence of the acidic pH prevailing in 
these granules. Iron depleted transferrin, still 
bound to its receptor, escapes lysosomal degrada- 
tion and is recycled back to the cell surface. This 
model was supported by the effect of 
lysosomotropic agents such as methylamine, which 
increases the intralysosomal pH and greatly in- 
hibits iron uptake from transferrin [ 151. 
A comparable model could be envisaged to ex- 
plain transferrin iron uptake by cultured 
hepatocytes if we could establish the presence of 
specific receptors for transferrin at the plasma 
membrane of hepatocytes, and if it could be shown 
that lysosomotropic drugs decrease iron uptake. 
3.2. Low temperature binding of transferrin 
Cultured hepatocytes were incubated for 1 h at 
4°C in the presence of increasing concentrations of 
‘H-labelled transferrin. As shown in fig. 2, the bin- 
ding of 3H-labelled material is essentially propor- 
tional to the extracellular concentration, indicating 
that the binding is largely non-specific. However, 
at very low concentration (0.5-5 pg Tf/ml) the ex- 
istence of a specific interaction cannot be excluded. 
To further investigate whether transferrin iron 
could be taken up by a non-specific mechanism 
(e.g., fluid phase endocytosis), or whether it could 
also result from a receptor-mediated process, we 
compared the uptake of transferrin iron to that of 
[3H]inulin, a marker of fluid phase endocytosis 
[25] and studied the effect of methylamine, a 
substance known to interact with endocytosis [26] 
and iron uptake [ 151. 
3.3. Uptake of [3H]inulin and 59Fe-labelled 
transferrin 
When cultured hepatocytes are incubated for 1 h 
1 
CONCENTRATION !ug/ml) 
Fig. 2. Low-temperature binding of transferrin. Cells 
(-2.5 mg protein) were incubated for 1 h at 4°C in 1 ml 
of culture medium containing increasing concentrations 
of ‘H-labelled transferrin (spec. act. as in fig. 1). After 
the incubation, the cells were washed, dissolved and 
analysed as in fig. 1. Mean results + SD of 3 different 
expts are given. 
at 37°C in the presence of increasing concentra- 
tions of ‘H-labelled inulin, the uptake of 3H is pro- 
portional to the extracellular concentration of the 
polysaccharide. This uptake corresponds to the in- 
teriorisation of 0.2 ~1 of extracellular medium. mg 
cell protein-’ .h-‘. Under the same conditions, 
when incubated in the presence of increasing 
concentrations of 59Fe-labelled transferrin, hepato- 
cytes accumulate 59Fe largely as a function of the 
external concentration with a clearance of 
0.3 ~1. mg cell protein-‘. h-’ (fig. 3A). 
3.4. Effect of methylamine 
Methylamine is a weak base which accumulates 
in lysosomes, increases the lysosomal pH [27], in- 
hibits lysosomal digestion [26] and decreases the 
rate at which the membrane of endocytic vesicles is 
recycled back to the plasma membrane [26]. Its ef- 
fect on iron and inulin accumulation in 
hepatocytes is illustrated in fig. 3B. At low exter- 
nal concentrations of transferrin (l-30 pg/ml) 
20 mM methylamine reduces 59Fe accumulation 
without any significant effect on inulin uptake. 
These results suggest hat while the accumulation 
of 3H-labelled inulin and 59Fe are comparable at 
high concentrations and could result mainly from 
367 
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Fig. 3. Accumulation of transferrin iron and inulin by 
cultured hepatocytes. Cells (-2.5 mg protein) were 
incubated for 1 h at 37°C in 1 ml of culture medium 
containing increasing concentrations of (0) “Fe-loaded 
transferrin or (m) ‘H-labelled inulin (spec. act. as in 
fig. 1) in the absence (A) or the presence (B) of 20 mM 
methylamine. At the end of the incubation, the cells were 
washed, dissolved and analysed as in fig. 1. 
fluid phase endocytosis, a process which is not af- 
fected by methylamine, at low concentrations 
(l-30 pug/ml) transferrin iron may be taken up by 
a more specific mechanism which is affected by the 
drug, such as receptor-mediated endocytosis. To 
reconcile this result with the low temperature- 
binding studies which suggested the absence of a 
specific receptor, we have considered the possibili- 
ty that transferrin receptors might be occupied 
by transferrin neo-synthesized by cultured 
hepatocytes. 
1 
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Fig. 4. Binding of anti-transferrin IgG to cultured 
hepatocytes. Cells (-2.5 mg protein) were incubated in 
20 cm2 Petri dishes for 1 h at 4°C culture medium 
containing increasing concentrations of 3H-labelled anti- 
transferrin IgG (0) or 3H-labelled non-specific IgG (m) 
(spec. act. as in fig. 1). Mean results + SD of 3 
independent expts are given. A represents the specific 
binding. 
3.5. The secretion of transferrin by cultured 
hepatocytes 
Since one of the physiological roles of 
hepatocytes is the synthesis and the secretion of 
transferrin, the appearance of rat transferrin in the 
extracellular medium of cultured hepatocytes was 
investigated. Our results indicate that every h, 
0.45 pg transferrin/mg cell protein appear in the 
culture medium. Thus, if there are specific recep- 
tors for transferrin at the plasma membrane, they 
would be occupied by the secreted transferrin. In 
order to confirm this hypothesis, we measured the 
binding of anti-transferrin IgG to cultured 
hepatocytes. 
3.6. Binding of anti-transferrin IgG to cultured 
hepatocytes 
Cultured rat hepatocytes were incubated for 1 h 
at 4°C in the presence of increasing concentrations 
of purified 3H-labelled anti-transferrin IgG. The 
same experiment was carried out with non-specific 
IgG. The results presented in fig. 4 indicate that 
the difference between the binding of anti- 
transferrin IgG and that of non-specific IgG results 
from a saturable process indicating a specific bin- 
ding of anti-transferrin IgG probably as a conse- 
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quence of the presence of transferrin at the plasma 
membrane. 
4. CONCLUSIONS 
Our results indicate that the binding of transfer- 
rin to cultured hepatocytes as well as transferrin 
iron uptake seem to be largely non-specific. 
However, the difference observed at 37°C between 
the accumulation of s9Fe and that of 3H-labelled 
transferrin implies the existence of a mechanism 
allowing the reutilisation of transferrin after iron 
delivery. 
The effect of methylamine reported here might 
suggest he existence of such a mechanism respon- 
sible for transferrin iron uptake by cultured 
hepatocytes. Whether the apparently non-specific 
character of transferrin binding is related to the 
presence of neo-synthesized transferrin at the 
plasma membrane associated with a specific recep- 
tor is currently under investigation. 
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